1. Home
  2. Latest Reports
  3. Global Remicade Drug Market

Global Remicade Drug Market Size and Overview

Remicade is an anti inflammatory medicine. Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha and is used to treat autoimmune diseases. Remicade can help treat a range of autoimmune conditions by relieving pain and reducing inflammation. It is usually used when other medicines or treatments have failed especially in adults.
The remicade drug market is segmented based on type, application, and geography. On the basis of type, remicade drug market divided into brands drugs and generic drugs. Further, the remicade drug market is segmented by application into disease, pediatric crohn's disease, ulcerative colitis, pediatric ulcerative colitis, and other. Geographically, the remicade drug market is sub-divided into North America, Europe, Asia-Pacific, and Rest of the world.
The key market players operating in the remicade drug market include Janssen, Hospira, Celltrion Healthcare, Epirus Biopharmaceuticals, and Samsung Bioepsis among others.
REMICADE DRUG MARKET SEGMENTS
Market By Type
•    Brands Drugs
•    Generic Drugs
Market By Application
•     Disease
•    Pediatric Disease
•    Ulcerative Colitis
•    Pediatric Ulcerative Colitis
•    Other
Market By Geography
•    North America
•    Europe
•    Asia-Pacific
•    Rest of the world
Key Players
•    Janssen
•    Hospira
•    Celltrion Healthcare
•    Epirus Biopharmaceuticals
•    Samsung Bioepsis

Executive Summary
1 Remicade (infliximab) Drug Market Overview
    1.1 Product Overview and Scope of Remicade (infliximab) Drug
    1.2 Remicade (infliximab) Drug Segment by Type
        1.2.1 Global Remicade (infliximab) Drug Production Growth Rate Comparison by Type (2014-2025)
        1.2.2 Brands Drugs
        1.2.3 Generic Drugs
    1.3 Remicade (infliximab) Drug Segment by Application
        1.3.1 Remicade (infliximab) Drug Consumption Comparison by Application (2014-2025)
        1.3.2 Crohn's Disease
        1.3.3 Pediatric Crohn's Disease
        1.3.4 Ulcerative Colitis
        1.3.5 Pediatric Ulcerative Colitis
        1.3.6 Other
    1.4 Global Remicade (infliximab) Drug Market by Region
        1.4.1 Global Remicade (infliximab) Drug Market Size Region
        1.4.2 North America Status and Prospect (2014-2025)
        1.4.3 Europe Status and Prospect (2014-2025)
        1.4.4 China Status and Prospect (2014-2025)
        1.4.5 Japan Status and Prospect (2014-2025)
    1.5 Global Remicade (infliximab) Drug Market Size
        1.5.1 Global Remicade (infliximab) Drug Revenue (2014-2025)
        1.5.2 Global Remicade (infliximab) Drug Production (2014-2025)

2 Global Remicade (infliximab) Drug Market Competition by Manufacturers
    2.1 Global Remicade (infliximab) Drug Production Market Share by Manufacturers (2014-2019)
    2.2 Global Remicade (infliximab) Drug Revenue Share by Manufacturers (2014-2019)
    2.3 Global Remicade (infliximab) Drug Average Price by Manufacturers (2014-2019)
    2.4 Manufacturers Remicade (infliximab) Drug Production Sites, Area Served, Product Types
    2.5 Remicade (infliximab) Drug Market Competitive Situation and Trends
        2.5.1 Remicade (infliximab) Drug Market Concentration Rate
        2.5.2 Remicade (infliximab) Drug Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Remicade (infliximab) Drug Production Market Share by Regions
    3.1 Global Remicade (infliximab) Drug Production Market Share by Regions
    3.2 Global Remicade (infliximab) Drug Revenue Market Share by Regions (2014-2019)
    3.3 Global Remicade (infliximab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
    3.4 North America Remicade (infliximab) Drug Production
        3.4.1 North America Remicade (infliximab) Drug Production Growth Rate (2014-2019)
        3.4.2 North America Remicade (infliximab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
    3.5 Europe Remicade (infliximab) Drug Production
        3.5.1 Europe Remicade (infliximab) Drug Production Growth Rate (2014-2019)
        3.5.2 Europe Remicade (infliximab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
    3.6 China Remicade (infliximab) Drug Production (2014-2019)
        3.6.1 China Remicade (infliximab) Drug Production Growth Rate (2014-2019)
        3.6.2 China Remicade (infliximab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
    3.7 Japan Remicade (infliximab) Drug Production (2014-2019)
        3.7.1 Japan Remicade (infliximab) Drug Production Growth Rate (2014-2019)
        3.7.2 Japan Remicade (infliximab) Drug Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Remicade (infliximab) Drug Consumption by Regions
    4.1 Global Remicade (infliximab) Drug Consumption by Regions
    4.2 North America Remicade (infliximab) Drug Consumption (2014-2019)
    4.3 Europe Remicade (infliximab) Drug Consumption (2014-2019)
    4.4 China Remicade (infliximab) Drug Consumption (2014-2019)
    4.5 Japan Remicade (infliximab) Drug Consumption (2014-2019)

5 Global Remicade (infliximab) Drug Production, Revenue, Price Trend by Type
    5.1 Global Remicade (infliximab) Drug Production Market Share by Type (2014-2019)
    5.2 Global Remicade (infliximab) Drug Revenue Market Share by Type (2014-2019)
    5.3 Global Remicade (infliximab) Drug Price by Type (2014-2019)
    5.4 Global Remicade (infliximab) Drug Production Growth by Type (2014-2019)

6 Global Remicade (infliximab) Drug Market Analysis by Applications
    6.1 Global Remicade (infliximab) Drug Consumption Market Share by Application (2014-2019)
    6.2 Global Remicade (infliximab) Drug Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Remicade (infliximab) Drug Business
    7.1 Janssen
        7.1.1 Janssen Remicade (infliximab) Drug Production Sites and Area Served
        7.1.2 Remicade (infliximab) Drug Product Introduction, Application and Specification
        7.1.3 Janssen Remicade (infliximab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
        7.1.4 Main Business and Markets Served
    7.2 Hospira
        7.2.1 Hospira Remicade (infliximab) Drug Production Sites and Area Served
        7.2.2 Remicade (infliximab) Drug Product Introduction, Application and Specification
        7.2.3 Hospira Remicade (infliximab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
        7.2.4 Main Business and Markets Served
    7.3 Celltrion Healthcare
        7.3.1 Celltrion Healthcare Remicade (infliximab) Drug Production Sites and Area Served
        7.3.2 Remicade (infliximab) Drug Product Introduction, Application and Specification
        7.3.3 Celltrion Healthcare Remicade (infliximab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
        7.3.4 Main Business and Markets Served
    7.4 Epirus Biopharmaceuticals
        7.4.1 Epirus Biopharmaceuticals Remicade (infliximab) Drug Production Sites and Area Served
        7.4.2 Remicade (infliximab) Drug Product Introduction, Application and Specification
        7.4.3 Epirus Biopharmaceuticals Remicade (infliximab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
        7.4.4 Main Business and Markets Served
    7.5 Samsung Bioepsis
        7.5.1 Samsung Bioepsis Remicade (infliximab) Drug Production Sites and Area Served
        7.5.2 Remicade (infliximab) Drug Product Introduction, Application and Specification
        7.5.3 Samsung Bioepsis Remicade (infliximab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
        7.5.4 Main Business and Markets Served

8 Remicade (infliximab) Drug Manufacturing Cost Analysis
    8.1 Remicade (infliximab) Drug Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
    8.3 Manufacturing Process Analysis of Remicade (infliximab) Drug
    8.4 Remicade (infliximab) Drug Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
    9.2 Remicade (infliximab) Drug Distributors List
    9.3 Remicade (infliximab) Drug Customers

10 Market Dynamics
    10.1 Market Trends
    10.2 Opportunities
    10.3 Market Drivers
    10.4 Challenges
    10.5 Influence Factors

11 Global Remicade (infliximab) Drug Market Forecast
    11.1 Global Remicade (infliximab) Drug Production, Revenue Forecast
        11.1.1 Global Remicade (infliximab) Drug Production Growth Rate Forecast (2019-2025)
        11.1.2 Global Remicade (infliximab) Drug Revenue and Growth Rate Forecast (2019-2025)
        11.1.3 Global Remicade (infliximab) Drug Price and Trend Forecast (2019-2025)
    11.2 Global Remicade (infliximab) Drug Production Forecast by Regions (2019-2025)
        11.2.1 North America Remicade (infliximab) Drug Production, Revenue Forecast (2019-2025)
        11.2.2 Europe Remicade (infliximab) Drug Production, Revenue Forecast (2019-2025)
        11.2.3 China Remicade (infliximab) Drug Production, Revenue Forecast (2019-2025)
        11.2.4 Japan Remicade (infliximab) Drug Production, Revenue Forecast (2019-2025)
    11.3 Global Remicade (infliximab) Drug Consumption Forecast by Regions (2019-2025)
        11.3.1 North America Remicade (infliximab) Drug Consumption Forecast (2019-2025)
        11.3.2 Europe Remicade (infliximab) Drug Consumption Forecast (2019-2025)
        11.3.3 China Remicade (infliximab) Drug Consumption Forecast (2019-2025)
        11.3.4 Japan Remicade (infliximab) Drug Consumption Forecast (2019-2025)
    11.4 Global Remicade (infliximab) Drug Production, Revenue and Price Forecast by Type (2019-2025)
    11.5 Global Remicade (infliximab) Drug Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Author List
    13.4 Disclaimer

Let us know more about your research need and we will customize an offer exclusively for you!
Let us know more about your research need and we will customize an offer exclusively for you!
Please Select Format
Enquiry About Report

More Information

Contact us
+91-9890799070
+1 321-441-4414
--- or ---
support@datananalysis.com

Testimonial

  • Linda Jacobson
    Director of Product Development

    Medical Devices manufacturing company at Canada

    I was looking for some elaborated details on blood bag got a reference from my colleague about them, and I was very much satisfied with the data on market segmentation and insights about global market, asked them if I can get it more customised hence they did elaborated it to huge 400 pages deep report in one week.Thanks guys will be back in future.

  • Mike Simmons
    Purchase Head

    Heavy machinery manufacturing company

    Did purchased a report from one of the vendor on Artificial Lift Market and I was depressed to see the very standard type of data included in the report, then again went back to hunt for something valuable and data driven report they asked me each and every details I want to see over the report and after a week of time got what I was looking for so not hesitant to refer back to them. Thanks victor for being prompt and professional.

  • Anna Stevenson
    Business Owner

    freelance software developer

    It’s been 8 years now I am developing and designing software as a freelance for various small and large scale organisations around globe and wanted to start my own software development consultancy firm, and I got hooked to their Mobile application market report and after a very thorough understanding of the report I have stepped my start-up into the customised mobile software market at Middle East, Africa and Asia Pacific.Thanks to Lee the Boss analyst  and victor for small discount.

  • Josh Bernard
    Owner, Designer, Artist

    Deals on customised automobile at USA

    I am one of the biggest enthusiast for custom jobs on cars, trucks and ships since childhood, so I own a custom automobile designing company and I was blown off to see beautiful custom paint work done on a Ford at one of the event and since that day I wanted to offer the same to my clients as well but I was not having too much of information on Electric paints, and fortunately I received message on LinkedIn from Data N Analysis team about their service, and now I am stuck  with three research report and contract signed for digital marketing as well. (Best of luck guys).

  • Neo Yang
    Chief Technical Officer

    Electronics Manufacturing company at Malaysia.

    Great team to have as a consultant, very sensible and professional service provided as per the scheduled timeline, what I like most about them is that they are straight forward with quality of service so if you are in hurry they will just say sorry we can’t compromise with our work. Look forward for more inputs guy’s thanks.

  • Follow us on:

© 2019 Data N Analysis. All Rights Reserved | Design by Data N Analysis